Cargando…
Do Support Vector Machines Play a Role in Stratifying Patient Population Based on Cancer Biomarkers?
Biomarkers are known to be the key driver behind targeted cancer therapies by either stratifying the patients into risk categories or identifying patient subgroups most likely to benefit. However, the ability of a biomarker to stratify patients relies heavily on the type of clinical endpoint data be...
Autores principales: | Lanza, Ben, Parashar, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611982/ https://www.ncbi.nlm.nih.gov/pubmed/34778890 |
Ejemplares similares
-
Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013) -
Type I error control in biomarker-stratified clinical trials
por: Parashar, Deepak, et al.
Publicado: (2015) -
Identification of osteoporosis based on gene biomarkers using support vector machine
por: Lv, Nanning, et al.
Publicado: (2022) -
Identifying cancer biomarkers by network-constrained support vector machines
por: Chen, Li, et al.
Publicado: (2011) -
Application of Support Vector Machines in Viral Biology
por: Modak, Sonal, et al.
Publicado: (2019)